Home / News / World News / Article / CAR T-cell therapy tested for rheumatoid arthritis to eliminate disease-driving B cells

CAR T-cell therapy tested for rheumatoid arthritis to eliminate disease-driving B cells

Patients receive brief chemotherapy before a single infusion of genetically reprogrammed T cells, which eliminate harmful B cells in the body

  • WhatsAppBookmarkBookmark
Listen to this article :
Inflammatory foci (magenta) are no longer detectable after the therapy. PIC COURTESY/Charite

Inflammatory foci (magenta) are no longer detectable after the therapy. PIC COURTESY/Charite

Conventional rheumatoid arthritis drugs continuously suppress immunity rather than removing disease-driving B cells.

To treat refractory cases, Charite researchers are testing CD19-targeted CAR T-cell therapy an advanced immunotherapy that genetically modifies a patient’s own immune T cells to recognise and destroy cancer cells

Read Next Story
Iran-Gulf foreign ministers’ meeting in Oman postponed amid Strait of Hormuz tensions

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All